NOVN - ノバン (Novan Inc.)

NOVNのニュース

   JTC Team to Host Virtual Investor Innovation in Dermatology Spotlight Event Featuring Novan, Inc.  2022/04/25 14:00:00 Wallstreet:Online
- Live video webcast event with members of Novan, Inc. management on Tuesday, April 26th at 2:00 PM ET -FRENCHTOWN, NJ / ACCESSWIRE / April 25, 2022 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today …
   Novan Inc. (NASDAQ: NOVN) Shares Have Been Down About -29.74% Year-To-Date Since The Beginning Of 2022  2022/04/23 17:00:00 Marketing Sentinel
During the last session, Novan Inc. (NASDAQ:NOVN)’s traded shares were 0.41 million, with the beta value of the company hitting 0.03. At the end of the trading day, the stock’s price was $2.93, reflecting an intraday loss of -1.68% or -$0.05. The 52-week high for the NOVN share is $20.74, that puts it down -607.85 … Novan Inc. (NASDAQ: NOVN) Shares Have Been Down About -29.74% Year-To-Date Since The Beginning Of 2022 Read More »
   Novan to Participate in the Virtual Investor Innovation in Dermatology Spotlight Event  2022/04/20 13:05:00 GlobeNewswire
Live moderated video webcast with members of the Novan management team on Tuesday, April 26th at 2:00 PM ET Live moderated video webcast with members of the Novan management team on Tuesday, April 26th at 2:00 PM ET
   Novan (NOVN) Investor Presentation - Slideshow  2022/03/25 18:10:08 Seeking Alpha
   2022 Women in Business Awards: Tomoko Maeda Chubachi – Novan  2022/03/25 03:00:00 Business Journals
Meet the winners in our 2022 Women in Business Awards!
   Novan (NOVN) Investor Presentation - Slideshow  2022/03/25 18:10:08 Seeking Alpha
   2022 Women in Business Awards: Tomoko Maeda Chubachi – Novan  2022/03/25 03:00:00 Business Journals
Meet the winners in our 2022 Women in Business Awards!
   Novan Announces Late-Breaking Abstract Accepted for Presentation at American Academy of Dermatology''s (AAD) 2022 Annual Meeting  2022/03/24 13:00:00 Benzinga
DURHAM, N.C., March 24, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ: NOVN ), today announced that data from its pivotal Phase 3 study of berdazimer gel 10.3% (SB206) for the treatment of molluscum contagiosum was selected for an oral presentation at a late-breaker session at the American Academy of Dermatology''s (AAD) 2022 Annual Meeting. Details of the abstract presentation are as follows: Title: Berdazimer 10.3% Gel (SB206): A Novel, Topical Nitric Oxide Releasing Medication: Results from a Pivotal Phase 3 Study in Patients (Children and Adults) with Molluscum Contagiosum Session: Clinical Studies/Pediatric Date & Time: March 26, 2022, at 10:20am ET Location: Rm. 253A The presentation will be given by Dr. John Browning M.D., F.A.A.D, F.A.A.P., MBA, Adjunct Associate Professor of Pediatrics and Dermatology at UT Health San Antonio and Baylor College of Medicine, and a Principal Investigator in the B-SIMPLE4 study. "We are pleased to present the compelling data from our Phase 3 study, BSIMPLE-4, at this prestigious dermatology event.
   Novan Acquires EPI Health To Bolster Commercial Force For Potential Marketing Of Its lead Products  2022/03/11 16:10:27 Benzinga
Novan Inc (NASDAQ: NOVN ) has acquired EPI Health LLC , a specialty pharmaceutical company focused on the U.S. dermatology market. EPI Health offers a product portfolio that includes four prescription products across psoriasis, rosacea, dermatosis, and acne, with a 2021 operating revenue of $17.6 million. Deal consideration of $27.5 million consists of $11.0 million in cash and $16.5 million in … Full story available on Benzinga.com
   Novan acquires EPI Health for upfront payment of $27.5M and milestone payment of $23.5M  2022/03/11 11:42:39 Seeking Alpha
Novan (NOVN) is acquiring EPI Health, LLC, a specialty pharmaceutical company focused on the U.S
   Novan (NOVN) Investor Presentation - Slideshow  2022/03/25 18:10:08 Seeking Alpha
   2022 Women in Business Awards: Tomoko Maeda Chubachi – Novan  2022/03/25 03:00:00 Business Journals
Meet the winners in our 2022 Women in Business Awards!
   Novan Announces Late-Breaking Abstract Accepted for Presentation at American Academy of Dermatology''s (AAD) 2022 Annual Meeting  2022/03/24 13:00:00 Benzinga
DURHAM, N.C., March 24, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ: NOVN ), today announced that data from its pivotal Phase 3 study of berdazimer gel 10.3% (SB206) for the treatment of molluscum contagiosum was selected for an oral presentation at a late-breaker session at the American Academy of Dermatology''s (AAD) 2022 Annual Meeting. Details of the abstract presentation are as follows: Title: Berdazimer 10.3% Gel (SB206): A Novel, Topical Nitric Oxide Releasing Medication: Results from a Pivotal Phase 3 Study in Patients (Children and Adults) with Molluscum Contagiosum Session: Clinical Studies/Pediatric Date & Time: March 26, 2022, at 10:20am ET Location: Rm. 253A The presentation will be given by Dr. John Browning M.D., F.A.A.D, F.A.A.P., MBA, Adjunct Associate Professor of Pediatrics and Dermatology at UT Health San Antonio and Baylor College of Medicine, and a Principal Investigator in the B-SIMPLE4 study. "We are pleased to present the compelling data from our Phase 3 study, BSIMPLE-4, at this prestigious dermatology event.
   Novan Acquires EPI Health To Bolster Commercial Force For Potential Marketing Of Its lead Products  2022/03/11 16:10:27 Benzinga
Novan Inc (NASDAQ: NOVN ) has acquired EPI Health LLC , a specialty pharmaceutical company focused on the U.S. dermatology market. EPI Health offers a product portfolio that includes four prescription products across psoriasis, rosacea, dermatosis, and acne, with a 2021 operating revenue of $17.6 million. Deal consideration of $27.5 million consists of $11.0 million in cash and $16.5 million in … Full story available on Benzinga.com
   Novan acquires EPI Health for upfront payment of $27.5M and milestone payment of $23.5M  2022/03/11 11:42:39 Seeking Alpha
Novan (NOVN) is acquiring EPI Health, LLC, a specialty pharmaceutical company focused on the U.S

calendar